[HTML][HTML] Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

YH Liao, RJ Hsu, TH Wang, CT Wu, SY Huang… - BMC …, 2020 - Springer
Background Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.

YH Liao, RJ Hsu, TH Wang, CT Wu, SY Huang… - BMC …, 2020 - europepmc.org
Background Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

[HTML][HTML] Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

YH Liao, RJ Hsu, TH Wang… - BMC …, 2020 - bmcgastroenterol.biomedcentral …
Aspirin has been found to lower the occurrence rates of some cancers through the inhibition
of the cyclooxygenase enzyme. For example, there is a well-known association between …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.

YH Liao, RJ Hsu, TH Wang, CT Wu, SY Huang, CY Hsu… - 2020 - cabidigitallibrary.org
Background: Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.

YH Liao, RJ Hsu, TH Wang, CT Wu… - BMC …, 2020 - search.ebscohost.com
Abstract < bold> Background: </bold> Aspirin has been found to lower the
occurrence rates of some cancers through the inhibition of the cyclooxygenase enzyme. For …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: A nationwide cohort study

YH Liao, RJ Hsu, TH Wang, CT Wu… - BMC …, 2020 - tcu.elsevierpure.com
Background: Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

YH Liao, RJ Hsu, TH Wang, CT Wu, SY Huang… - BMC …, 2020 - go.gale.com
Background Hepatocellular carcinoma (HCC) is one of the most common malignant
neoplasms in the world. The incidence of HCC has increased not only in the United States …

[HTML][HTML] Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

YH Liao, RJ Hsu, TH Wang, CT Wu… - BMC …, 2020 - ncbi.nlm.nih.gov
Background Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

YH Liao, H Ren-Jun, TH Wang… - BMC …, 2020 - search.proquest.com
Background Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …

Aspirin Decreases Hepatocellular Carcinoma Risk in Hepatitis C Virus Carriers: A Nationwide Cohort Study

YH Liao, RJ Hsu, TH Wang, CT Wu, SY Huang, CY Hsu… - 2019 - researchsquare.com
Background Aspirin has been found to lower the occurrence rates of some cancers through
the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association …